452 related articles for article (PubMed ID: 17213460)
1. Differences in prescription drug use in HMO and self-insured health plans.
Wallack SS; Thomas CP; Martin TC; Ryan A
Med Care Res Rev; 2007 Feb; 64(1):98-116. PubMed ID: 17213460
[TBL] [Abstract][Full Text] [Related]
2. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
3. Does competition by health maintenance organizations affect the adoption of cost-containment measures by fee-for-service plans?
Joesch JM; Wickizer TM; Feldstein PJ
Am J Manag Care; 1998 Jun; 4(6):832-8. PubMed ID: 10181069
[TBL] [Abstract][Full Text] [Related]
4. Impact of HMO ownership on management processes and utilization outcomes.
Ahern M; Molinari C
Am J Manag Care; 2001 May; 7(5):489-97. PubMed ID: 11388128
[TBL] [Abstract][Full Text] [Related]
5. Decomposing pharmaceutical cost growth in different types of health plans.
Chernew ME; Smith DG; Kirking DM; Fendrick AM
Am J Manag Care; 2001 Jul; 7(7):667-73. PubMed ID: 11464425
[TBL] [Abstract][Full Text] [Related]
6. Use of ineffective or unsafe medications among members of a Medicare HMO compared to individuals in a Medicare fee-for-service program.
Futterman R; Fillit H; Roglieri JL
Am J Manag Care; 1997 Apr; 3(4):569-75. PubMed ID: 10169525
[TBL] [Abstract][Full Text] [Related]
7. The effect of incentive-based formularies on prescription-drug utilization and spending.
Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG
N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430
[TBL] [Abstract][Full Text] [Related]
8. Rapid change to HMO systems: profile of the Dane County, Wisconsin, experience.
Scheckler WE; Schulz R
J Fam Pract; 1987 Apr; 24(4):417-24. PubMed ID: 3559496
[TBL] [Abstract][Full Text] [Related]
9. The magnitude and nature of risk selection in employer-sponsored health plans.
Nicholson S; Bundorf K; Stein RM; Polsky D
Health Serv Res; 2004 Dec; 39(6 Pt 1):1817-38. PubMed ID: 15533189
[TBL] [Abstract][Full Text] [Related]
10. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
[TBL] [Abstract][Full Text] [Related]
11. Prescription drugs: issues of cost, coverage, and quality.
Copeland C
EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
[TBL] [Abstract][Full Text] [Related]
12. Employer-sponsored Medicare HMO strategies: common selection criteria.
Paik JY
Manag Care Q; 1997; 5(4):55-61. PubMed ID: 10175721
[TBL] [Abstract][Full Text] [Related]
13. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
Saleh SS; Weller W; Hannan E
J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
[TBL] [Abstract][Full Text] [Related]
14. What is the HMO Act and what is its impact on employers?
Sloan A
Employee Relat Law J; 1979; 4(4):608-12. PubMed ID: 10294900
[TBL] [Abstract][Full Text] [Related]
15. Health maintenance organizations: structure, performance, and current issues for employee health benefits design.
Gold M
J Occup Med; 1991 Mar; 33(3):288-96. PubMed ID: 1903152
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of a consumer-driven health plan on medical care expenditures and utilization.
Parente ST; Feldman R; Christianson JB
Health Serv Res; 2004 Aug; 39(4 Pt 2):1189-210. PubMed ID: 15230920
[TBL] [Abstract][Full Text] [Related]
17. How effectively do managed care organizations influence prescribing and dispensing decisions?
Carroll NV
Am J Manag Care; 2002 Dec; 8(12):1041-54. PubMed ID: 12500881
[TBL] [Abstract][Full Text] [Related]
18. Managing drug costs: the perception of managed care pharmacy directors.
Litton LM; Sisk FA; Akins ME
Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
[TBL] [Abstract][Full Text] [Related]
19. The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare revisited.
Batata A
J Health Econ; 2004 Sep; 23(5):951-63. PubMed ID: 15353188
[TBL] [Abstract][Full Text] [Related]
20. Effects of generic-only drug coverage in a Medicare HMO.
Christian-Herman J; Emons M; George D
Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-455-68. PubMed ID: 15471765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
